ANDA Stability Requirements To Be Broadly Grandfathered, FDA Says
This article was originally published in PharmAsia News
Executive Summary
In a win-win for agency and industry, generic applications submitted before deadline for new stability requirements still will be judged by old standards, even if the ANDAs are amended or resubmitted.
You may also be interested in...
ANDA Avalanche: How Will FDA Deal With The 600 Received This Month?
Experts say one idea may be to borrow some new drug staff to help relieve the pressure; FDA says it will use all available resources.
FDA Will Allow ANDA Corrections … Until 10 Minor Deficiencies Found
GDUFA refuse-to-receive draft guidance says that agency will allow sponsors to make a few small fixes to their applications, but FDA won’t accept any ANDAs that have big problems.
Generic 180-Day Exclusivities Might Be Imperiled By ANDA Stability Guidance
Industry experts predict generic company pushback on some aspects of Q&A draft guidance and worry about unintended consequences, including impact on drug master files.